'Spanish Flu' Pandemic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Influenza: Pigs, People & Public Health
National Pork Board | 800-456-7675 | pork.org Public Health Fact Sheet Influenza: Pigs, People & Public Health Authors: Amy L. Vincent, DVM, PhD, USDA-ARS National Animal Disease Center; Marie R. Culhane, DVM, PhD, College of Veterinary Medicine, University of Minnesota; Christopher W. Olsen, DVM PhD, School of Veterinary Medicine and School of Medicine and Public Health, University of Wisconsin-Madison. Reviewers: Jeff B. Bender, DVM MS, University of Minnesota; Andrew Bowman, DVM PhD, The Ohio State University; Todd Davis, PhD, CDC; Ellen Kasari, DVM MS, USDA; Heather Fowler, VMD PhD MPH, National Pork Board Influenza A viruses (IAV) were first isolated from swine in the United States in 1930. Since that time, they remain an economically important cause of respiratory disease in pigs throughout the world and a public health risk. The clinical signs/symptoms of influenza in pigs and people are remarkably similar, with influenza-like illness (ILI) consisting of fever, lethargy, lack of appetite and coughing promi- nent in both species. Influenza viruses can be directly transmitted from pigs to people as “zoonotic” disease agents (pathogens that are transmitted from animals to humans or shared by animals and humans) and cause human infections. Conversely, influenza viruses from people can also infect and cause disease in pigs. These interspecies infections are most likely to occur when people and pigs are in close proximity with one another, such as during livestock exhibits at fairs, live animal markets, swine production barns, and slaughterhouses. Finally, pigs can serve as intermediaries in the generation of novel reassorted influenza viruses since they are also susceptible to infection with avian influenza viruses. -
Antiviral Agents Active Against Influenza a Viruses
REVIEWS Antiviral agents active against influenza A viruses Erik De Clercq Abstract | The recent outbreaks of avian influenza A (H5N1) virus, its expanding geographic distribution and its ability to transfer to humans and cause severe infection have raised serious concerns about the measures available to control an avian or human pandemic of influenza A. In anticipation of such a pandemic, several preventive and therapeutic strategies have been proposed, including the stockpiling of antiviral drugs, in particular the neuraminidase inhibitors oseltamivir (Tamiflu; Roche) and zanamivir (Relenza; GlaxoSmithKline). This article reviews agents that have been shown to have activity against influenza A viruses and discusses their therapeutic potential, and also describes emerging strategies for targeting these viruses. HXNY In the face of the persistent threat of human influenza A into the interior of the virus particles (virions) within In the naming system for (H3N2, H1N1) and B infections, the outbreaks of avian endosomes, a process that is needed for the uncoating virus strains, H refers to influenza (H5N1) in Southeast Asia, and the potential of to occur. The H+ ions are imported through the M2 haemagglutinin and N a new human or avian influenza A variant to unleash a (matrix 2) channels10; the transmembrane domain of to neuraminidase. pandemic, there is much concern about the shortage in the M2 protein, with the amino-acid residues facing both the number and supply of effective anti-influenza- the ion-conducting pore, is shown in FIG. 3a (REF. 11). virus agents1–4. There are, in principle, two mechanisms Amantadine has been postulated to block the interior by which pandemic influenza could originate: first, by channel within the tetrameric M2 helix bundle12. -
1918/19: 100 Years On
ESSAYS Ewald Frie 1918/19: 100 YEARS ON Open Futures 1918/19 – War and victory, collapse and defeat, revolution and reform, peace and re- organisation, civil war and violence, famine and Spanish flu and much else. The elements can be separated analytically, and many of them have been analysed individually in a historical context. They have been interpreted and incorporated into the narratives of revolution research, the history of warfare and violence, peace research, the history of diseases and epidemics. But the historical dynamics of 1918/19 resulted from the interplay of the various elements in very different constellations. 1918/19 is therefore a challeng- ing anniversary for a historical scholarship that is exploring new conceptual territory: – spatially: leaving the construct of the nation state and instead ›playing with scales‹1 from the local to the global; – temporally: departing from era- and progress-based master narratives and instead ›zooming in and out‹ and playing with temporal perspectives;2 – conceptually: departing from conceptual constructs due to the blurring of categories like ›crisis‹3 or ›revolution‹4 and instead focusing on a broad range of phenomena of social transformation on the premise of ›multidimensional understandings of emergence and destabilization‹.5 1 E.g. James Retallack (ed.), Imperial Germany 1871–1918, Oxford 2008. 2 E.g. Emily S. Rosenberg (ed.), A World Connecting. 1870–1945, Cambridge 2012 (A History of the World, ed. by Akira Iriye and Jürgen Osterhammel). 3 Cf. Thomas Mergel (ed.), Krisen verstehen. Historische und kulturwissenschaftliche Annäherungen, Frankfurt a.M. 2012, pp. 9-22, and the Leibniz Research Alliance ›Crises in a Globalised World‹: <http://www.leibniz-krisen.de/en/start/>. -
Questions & Answers on Influenza
101 Questions & Answers on Influenza101 101 Questions & Answers Prof. Dr. A.D.M.E. (Ab) Osterhaus is David De Pooter is working at Link Inc on professor of virology at Erasmus Medical since 2003, the Antwerp (Belgium) based Centre Rotterdam, and professor of communication consultancy agency, Environmental Virology at the Utrecht specialised in strategic communication University. Fascinated by the ingenious and social marketing. Link Inc is working ways viruses circumvent the immune with the European Scientific working Influenza system of their hosts to multiply and Group on Influenza (ESWI) since 1998 and spread, Osterhaus started his quest at the is taking care of the positioning of the interface of virology and immunology. He group, the strategy and the implementa Ab Osterhaus quickly translated new insights in this tion of the strategy by developing complex field to applications in animal and targeted communication tools. In this human vaccinology. In addition, he started capacity, David De Pooter is a professional David De Pooter his work on virus discovery, not only writer on medical topics and a communi focussing on the identification of a series cation manager of ESWI. As such he has of animal viruses, but also of new human established a fruitful and long standing viruses. collaboration with Prof Ab Osterhaus. (www.linkinc.be) 101 Questions & Answers on Influenza 101 101 Questions & Answers on Influenza Ab Osterhaus David De Pooter Elsevier, Maarssen © Elsevier, Maarssen 2009 Design: Studio Bassa, Culemborg Elsevier is an imprint of Reed Business bv, PO Box 1110, 3600 BC Maarssen, The Netherlands. To order: Elsevier Gezondheidszorg, Marketing dept., Antwoordnummer 2594 (freepost), 3600 VB Maarssen, The Netherlands. -
The Forgotten Fronts the First World War Battlefield Guide: World War Battlefield First the the Forgotten Fronts Forgotten The
Ed 1 Nov 2016 1 Nov Ed The First World War Battlefield Guide: Volume 2 The Forgotten Fronts The First Battlefield War World Guide: The Forgotten Fronts Creative Media Design ADR005472 Edition 1 November 2016 THE FORGOTTEN FRONTS | i The First World War Battlefield Guide: Volume 2 The British Army Campaign Guide to the Forgotten Fronts of the First World War 1st Edition November 2016 Acknowledgement The publisher wishes to acknowledge the assistance of the following organisations in providing text, images, multimedia links and sketch maps for this volume: Defence Geographic Centre, Imperial War Museum, Army Historical Branch, Air Historical Branch, Army Records Society,National Portrait Gallery, Tank Museum, National Army Museum, Royal Green Jackets Museum,Shepard Trust, Royal Australian Navy, Australian Defence, Royal Artillery Historical Trust, National Archive, Canadian War Museum, National Archives of Canada, The Times, RAF Museum, Wikimedia Commons, USAF, US Library of Congress. The Cover Images Front Cover: (1) Wounded soldier of the 10th Battalion, Black Watch being carried out of a communication trench on the ‘Birdcage’ Line near Salonika, February 1916 © IWM; (2) The advance through Palestine and the Battle of Megiddo: A sergeant directs orders whilst standing on one of the wooden saddles of the Camel Transport Corps © IWM (3) Soldiers of the Royal Army Service Corps outside a Field Ambulance Station. © IWM Inside Front Cover: Helles Memorial, Gallipoli © Barbara Taylor Back Cover: ‘Blood Swept Lands and Seas of Red’ at the Tower of London © Julia Gavin ii | THE FORGOTTEN FRONTS THE FORGOTTEN FRONTS | iii ISBN: 978-1-874346-46-3 First published in November 2016 by Creative Media Designs, Army Headquarters, Andover. -
The Spanish Flu
through electron microscopes, would that actually than normal for the elderly. The common have empowered them to halt the pandemic? explanation is that this strain of influenza was so There was no cure for the disease then, or now. new that it startled its victims' immune systems Vaccines? Another generation would pass before into overreaction, and the more vigorous the even partially effective vaccines against victim, the greater and deadlier the overreaction. influenza were developed. Even if all the The defensive swelling of membranes and knowledge and technology to produce flu increased secretion of fluids of the respiratory vaccine had been at hand in 1918, would it have system went to extremes in young adults, filling been possible to produce it in sufficient quantity their lungs with liquid until they drowned. and to distribute it across oceans and continents Overstimulation of the immune system is a in time to stop the swiftly spreading breath- plausible theory, but we could subject it to borne pandemic? Even today, when similar rigorous testing only if something like the 19 18 questions are asked each time a new virus returned. strain of the virus appears, the answer falls short of This distinctive influenza epidemic swept over being a confident "yes.” the world in three major waves during 1918 and 1919. We cannot be sure where and when the The influenza of the 1900s is still something of an initial wave in the spring of 1918 started, but the enigma, but the influenza that was sweeping around earliest scientific and statistical evidence points the world at the time of the Armistice ending to the United States in March 1918. -
The Role of Pawnshops in Risk Coping in Early Twentieth-Century Japan∗ Tatsuki Inoue†
The role of pawnshops in risk coping in early twentieth-century Japan∗ Tatsuki Inoue† Abstract This study examines the role of pawnshops as a risk-coping device in prewar Japan. Using data on pawnshop loans for more than 250 municipalities and exploiting the 1918–1920 influenza pandemic as a natural experiment, we find that the adverse health shock increased the total amount of loans from pawnshops. This is because those who regularly relied on pawnshops borrowed more money from them than usual to cope with the adverse health shock, and not because the number of people who used pawnshops increased. Keywords: Pawnshop; Risk-coping strategy; Borrowing; Influenza pandemic; Prewar Japan ∗ I would like to express my gratitude to Tetsuji Okazaki, Kota Ogasawara, and participants at the Economic History Society Annual Conference 2019 at Queen’s University Belfast and 2019 Japanese Economic Association Spring Meeting at Musashi University for their helpful comments. This work was supported by Grant-in-Aid for JSPS Fellows (Grant Number: 17J03825). Any errors are my own. † Graduate School of Economics, The University of Tokyo, Akamon General Research Building, 3F 353, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: inoue- [email protected]. 1 Introduction Most industrialized countries were characterized by huge income inequality before World War II (Piketty 2014). Since formal systems of social insurance were underdeveloped, the poor were more vulnerable to unforeseen accidents such as illness than today’s poor people in developed countries. Furthermore, an increase in migration removed people from the traditional informal social insurance systems provided by their local communities (Gorsky 1998). -
AJIC-Oseltamivir-Stockpile-Paper.Pdf
American Journal of Infection Control 45 (2017) 303-5 Contents lists available at ScienceDirect American Journal of Infection Control American Journal of Infection Control journal homepage: www.ajicjournal.org Brief Report Oseltamivir for pandemic influenza preparation: Maximizing the use of an existing stockpile Twisha S. Patel PharmD a, Sandro Cinti MD b, Duxin Sun PhD c, Siwei Li PhD c, Ruijuan Luo PhD c, Bo Wen PhD c, Brian A. Gallagher JD d,e, James G. Stevenson PharmD a,c,* a Pharmacy Services, University of Michigan Health System, Ann Arbor, MI b Infectious Diseases, University of Michigan Health System, Ann Arbor, MI c University of Michigan College of Pharmacy, Ann Arbor, MI d Marshall University School of Pharmacy, Huntington, WV e Joan C. Edwards School of Medicine, Huntington, WV With the threat of significant morbidity and mortality following an influenza pandemic, stockpiling of antiviral agents such as oseltamivir is recommended. Shelf-life extension was explored to maximize use of an existing stockpile. This analysis demonstrated that oseltamivir retains potency defined by United States Pharmacopeia acceptance criteria beyond the labeled expiration date. © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. BACKGROUND hospital employees because up to 35% are expected to become ill even with the institution of optimal infection control practices during Infection with the influenza virus can lead to devastating com- an influenza pandemic.7 Although imperative, this strategy created plications, including mortality.1 The influenza pandemic in 1918 and asignificantfinancialburdenonourinstitution:A5-daytreat- the Asian H5N1 outbreak in 2005 taught our nation a valuable lesson ment course of oseltamivir is considerably expensive ($120/box of about the importance of creating a national preparedness plan to 10 75-mg capsules, University of Michigan Health System, unpub- combat the spread of infection. -
Speed Enforcement – Web Text
Speed Enforcement – Web text Speed Enforcement Please refer to this document as: SafetyNet (2009) Speed Enforcement, retrieved <add date of retrieval here> Project co-financed by the European Commission, Directorate-General Transport and Energy 16/10/2009 Page 1 Speed Enforcement – Web text Speed Enforcement................................................................................................................3 1. General introduction to traffic law enforcement ...........................................................4 1.1 Police enforcement as part of a systems approach .............................................4 1.2 From laws and policy, to increased enforcement, to social benefits ...................4 1.3 General deterrence vs. specific deterrence.........................................................5 1.4 Targeted enforcement.........................................................................................6 2. Speed enforcement ....................................................................................................6 2.1 Speed enforcement as part of a speed management policy................................6 2.2 Speed enforcement in relation to other road safety measures.............................7 2.3 General characteristics of effective speed enforcement ......................................7 2.4 Public support for speed enforcement.................................................................7 3. Speed enforcement techniques and their effectiveness ..............................................8 -
The Spanish Flu and the First World War: a Historical Analysis of the Pandemic’S Impact on the Conduct of War and Its Lessons for the British Army of 2020
CHACR IN DEPTH BRIEFING CIRCULATION: PUBLIC 6 MAY 2020 The Spanish Flu and the First World War: A Historical Analysis of the Pandemic’s Impact on the Conduct of War and its Lessons for the British Army of 2020 Soldiers from Fort Riley, Kansas, ill with Spanish flu at a hospital ward at Camp Funston . From Otis Historical Archives, National Museum of Health and Medicine The influenza pandemic, also known as the Spanish Flu, which hit the World the 1918 and last- ed until 1920, was the deadliest outbreak of disease in the 20th century. The aim of this study is to analyse the impact that the pandemic had on the belligerent nations of the First World War and, in particular, their armies. How were the armies affected, what impact did the pan- demic have on the ability to fight, and what measures did the armies take to contain the vi- rus? Last, but not least, the study will offer some possible consequences and lessons for the British Army of today. Considering that CHACR supports the British Army, it is fitting that the emphasis lies on the UK experience of the Spanish Flu; however, other armies and nations are also taken into consideration to present a more all-encompassing picture of the situation and challenges that the Spanish Flu presented at the end of the First World War. IN DEPTH BRIEFING Page 2 In order to answer the questions above, the study is divided into three parts. Part one presents an overview of the Spanish Flu pandemic and thus provides the context for the following parts. -
Transcription, Client Name, Event Date, EV000XXXXX
Transcription, Solvay 29.07.2020 Results Overview Operator Ladies and gentlemen, welcome to Solvay Q2 2020 Results Conference Call for analysts and investors. Solvay team, the floor is yours. Jodi Allen Good afternoon and welcome to our second quarter 2020 earnings call. My name is Jodi Allen, Head of Investor Relations, and I'm joined virtually by our CEO, Ilham Kadri, and our CFO, Karim Hajjar. Today's call is being recorded and will be made available for replay on the investor relations section of our website. I would like to remind all participants that the presentation includes forward-looking statements which are subject to risk and uncertainties. You may refer to the slides related to today's broadcast which are available on our website. With that, I'll turn the call over to Ilham. Ilham Kadri Thank you, Jodi, and hello everyone. I hope you and your family are staying healthy during this continuing challenging time. At Solvay, health, safety and security of employees remain our number one priority. We continue to have 10,000 employees, or 42% of our human capital working in a virtual capacity, and we will take a cautious and progressive approach to the confinement over the coming month. The recent spike in COVID cases in certain parts of the world have increased our numbers slightly. Today, we have 40 colleagues who are infected with COVID-19 and 176 employees in quarantine. We wish our colleagues a quick and complete recovery and we will continue to take a disciplined approach to managing the safety of our employees. -
HHS 2009 H1N1 Influenza Improvement Plan
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 2009 H1N1 Influenza Improvement Plan May 29, 2012 TABLE OF CONTENTS Contents STATEMENT BY SECRETARY SEBELIUS.......................................................................... iii EXECUTIVE SUMMARY ......................................................................................................... iv CHAPTER 1: INTRODUCTION................................................................................................ 1 CHAPTER 2: DETECTION AND CHARACTERIZATION OF A FUTURE INFLUENZA PANDEMIC ................................................................................................................................... 5 CHAPTER 3: COMMUNITY MITIGATION MEASURES ................................................... 8 CHAPTER 4: MEDICAL SURGE CAPACITY ..................................................................... 12 CHAPTER 5: MEDICAL COUNTERMEASURES (MCM) FOR INFLUENZA OTHER THAN VACCINES ..................................................................................................................... 17 CHAPTER 6: VACCINE MANUFACTURING, DISTRIBUTION, AND POST- DISTRIBUTION......................................................................................................................... 25 CHAPTER 7: COMMUNICATIONS....................................................................................... 17 CHAPTER 8: CROSS-CUTTING PREPAREDNESS ISSUES............................................ 33 CHAPTER 9: INTERNATIONAL PARTNERSHIPS AND CAPACITY BUILDING ACTIVITIES